Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04200534 · ClinicalTrials.gov registry record · Early Phase 1
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)
A Early Phase 1 study of Lung Cancer and Smoking, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 358
- Enrollment target
- 3
- Study locations
NCT04200534 is a Early Phase 1 study of Lung Cancer and Smoking that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 358 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (62% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04200534, a Early Phase 1 study of Lung Cancer and Smoking, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 358 participants
- Enrollment target
- 3
- Study locations
Study Summary
This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are referred to a dedicated tobacco treatment program where they receive both the shared decision-making and initiate smoking cessation counseling prior to their visit with a primary care provider. Utilizing the centralized care model may work better in helping people quit smoking and make informed decisions about lung cancer screening compared to usual care.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Tobacco Cessation Counseling
- DRUG Nicotine Patch
Study Locations (3)
Texas
- University of Texas Medical Branch - Galveston
- M D Anderson Cancer Center - Houston
- University of Texas Health Science Center at Tyler - Tyler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2020-07-31 |
| Est. Completion | 2027-02-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04200534
The ClinicalTrials.gov registry entry for NCT04200534 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (62% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04200534 reports 3 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04200534 about?
NCT04200534 is a clinical study titled "Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)". This trial studies how well a centralized care strategy works in improving the quality of smoking cessation and shared decision making among patients who smoke and are considering lung cancer screening. The centralized care strategy is a model where smokers eligible for lung cancer screening are ref...
What is the current status of trial NCT04200534?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 358 participants. The study started on 2020-07-31. Estimated completion is 2027-02-28.
What conditions does trial NCT04200534 study?
This clinical trial studies the following conditions: Lung Cancer, Smoking.
What interventions are being tested in trial NCT04200534?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Tobacco Cessation Counseling (OTHER), Nicotine Patch (DRUG).
Who is sponsoring clinical trial NCT04200534?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04200534 being conducted?
This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
RECRUITING · Early Phase 1
-
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
RECRUITING · Early Phase 1
-
Microdevice for Evaluating Drug Response in Site in Lung Lesions
COMPLETED · Early Phase 1
-
Health Opportunities and Promoters of Equitable Screening for Lung Cancer
RECRUITING
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.